Lexapro (escitalopram) is not a controlled substance. It has no DEA schedule classification, meaning the federal government does not regulate it the same way it regulates drugs with recognized abuse potential, such as opioids, benzodiazepines, or stimulants. You can get a standard prescription for Lexapro without the extra restrictions that come with controlled medications.
What “Controlled Substance” Actually Means
The DEA assigns drugs to one of five schedules (I through V) based on how likely they are to be abused and whether they have accepted medical use. Schedule I drugs (like heroin) have high abuse potential and no approved medical purpose. Schedule II through V drugs have legitimate medical uses but carry varying levels of abuse risk. Benzodiazepines like Xanax, for instance, sit at Schedule IV.
Lexapro falls outside this system entirely. Its DEA schedule is listed as “None,” which means it is a prescription medication but not a controlled one. You still need a doctor’s prescription to get it, but pharmacies don’t face the same dispensing limits, and your doctor doesn’t need to use a special prescription pad or comply with refill restrictions the way they would for a controlled drug.
Why Lexapro Has Low Abuse Potential
Lexapro works by blocking the reabsorption of serotonin in the brain, which gradually raises serotonin levels over weeks. This slow, steady effect is fundamentally different from the rapid dopamine surge produced by drugs people typically abuse. Lexapro has very little effect on dopamine pathways, and it doesn’t bind to the receptors associated with addictive drugs, including benzodiazepine receptors, opioid-related pathways, or dopamine receptors.
Animal studies found low abuse liability, and clinical trials before the drug went to market did not reveal any drug-seeking behavior among participants. Lexapro doesn’t produce a “high,” doesn’t create tolerance to its antidepressant effect (even after five weeks of continuous use in animal models), and doesn’t reinforce the compulsive pattern of use that defines addiction. As of the most recent FDA label revision in 2025, the drug’s status remains unchanged: escitalopram is explicitly not a controlled substance.
Discontinuation Is Not the Same as Withdrawal
This is the part that causes the most confusion. Even though Lexapro isn’t addictive, your body does adjust to its presence over time. If you stop taking it abruptly, you can experience what’s called antidepressant discontinuation syndrome. Symptoms typically start within two to four days of stopping and can include flu-like feelings (fatigue, headache, achiness, sweating), nausea, dizziness, tingling or shock-like sensations, vivid dreams, and mood changes like irritability or anxiety.
These symptoms look uncomfortable, and some people understandably call it “withdrawal.” But the underlying process is different from the withdrawal seen with addictive substances. Your brain is readjusting its serotonin signaling, not craving a drug it has become dependent on in the way it would with an opioid or benzodiazepine. There’s no escalating need for higher doses and no compulsive drug-seeking involved.
Most cases of discontinuation syndrome are mild and resolve within eight weeks. Research shows that about 7% of people still have symptoms at the two-month mark, 6% at one year, and only 2% beyond three years. The standard approach to avoiding it is a gradual taper, reducing your dose in steps rather than stopping all at once.
How Prescriptions Differ From Controlled Drugs
Because Lexapro isn’t scheduled, the prescription process is simpler in several practical ways. Your doctor can call in or electronically send refills without the restrictions that apply to controlled substances. There’s no limit on the number of refills allowed per prescription. You won’t face the requirement to see your doctor every 30 days just to get a new script, and pharmacies won’t need to log your purchase in a state prescription drug monitoring program.
That said, Lexapro is still a prescription-only medication. You can’t buy it over the counter, and a healthcare provider needs to evaluate whether it’s appropriate for you before writing that prescription. The fact that it isn’t controlled reflects its safety profile, not a lack of need for medical oversight. Adjusting doses and tapering off the drug both benefit from professional guidance, particularly given the possibility of discontinuation symptoms.